Diabetic retinopathy

Annals of the Academy of Medicine Singapore

Volumn 29, Issue 6, 2000, Pages 745-752

  Wong, J S ^a,d   Aiello, L P ^b,c  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Joslin Institute   (United States)

^d UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Classification; Diabetes mellitus; Diagnosis; Management; Ocular complications

Indexed keywords

CLASSIFICATION; DIABETIC RETINOPATHY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; PROGNOSIS; REVIEW; RISK FACTOR; SINGAPORE;

DIABETIC RETINOPATHY; FEMALE; HUMANS; INCIDENCE; MALE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SINGAPORE;

EID: 0034331093     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Diabetes Mellitus. In: National Health Survey 1998. Epidemiology & Disease Control Department. Singapore: Ministry of Health, 1999:5-9.
2. Tan C E, Emmanuel S C, Tan B Y, Jacob E. Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care 1999; 22: 241-7.
3. Klein R, Kelin B E K, Moss S E, Davis M D, DeMets D L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102:520-6.
4. Klein R, Kelin B E K, Moss S E, Davis M D, DeMets D L. The Wisconsin Epidemiologic Stu dy of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102:527-32.
5. Kahn H A, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol 1974; 78:58-67.
6. Palmberg P F. Diabetic retinopathy. Diabetes 1977; 26:703-9.
7. Diabetes Control and Complications Trial Research Group. The relationship of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993; 329:977-86.
8. UKPDS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-53.
9. Diabetes Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: Clinical applications of Diabetes Retinopathy Study findings, DRS Report No. 8. Ophthalmology 1981; 88:583-600.
10. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. ETDRS Report No. 1. Arch Ophthalmol 1985; 103:1796-806.
11. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS Report No. 9. Ophthalmology 1991; 98:766-85.
12. Aiello L P, GardnerT W, King G L, Blakenship G, Cavallerano J D, Ferris F L, et al. Diabetes retinopathy (technical review). Diabetes Care 1998; 21:143-56.
13. Ferris F L. How effective are treatments for diabetic retinopathy. JAMA 1993; 269:1290-1.
14. Konno S, Feke G T, Yoshida A, Fujio N, Goger D G, Buzney S M. Retinal blood flow changes in Type 1 diabetes. A long-term follow-up study. Invest Ophthalmol Vis Sci 1996; 37:1140-8.
15. Grunwald J E, Riva C E, Martin D B, Quint A R, Epstein P A. Effect of an insulin-induced decrease in blood glucose on the human diabetic retinal circulation. Ophthalmology 1987; 94:1614-20.
16. Bursell S E, Clermont A C, Kinsley B T, Simonson D C, Aiello L M, Wolpert H A. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci 1996; 37:886-97.
17. Patel V, Rassam S, Newsom R, Wiek J, Kohner E. Retinal blood How in diabetic retinopathy. BMJ 1992; 305:678-83.
18. Engerman R L, Kern T S. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 1987; 36:808-12.
19. Speiser P, Gittelsohn A M, Patz A. Studies on diabetic retinopathy. 3. Influence of diabetes on intramural pericytes. Arch Ophthalmol 1968; 80:332-7.
20. Sosula L, Beaumont P, Hollows F C, Jonson K M. Dilatation and endothelial proliferation of retinal capillaries instreptozotocin-diabeticrats: quantitative electron microscopy. Invest Ophthalmol 1972; 11:926-35.
21. Stilt A W, Gardiner T A, Archer D B. Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. Br J Ophthalmol 1995; 79:362-7.
22. Cunha-Vaz J, Faria de Abreu J R, Campos A J. Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol 1975; 59:649-56.
23. Iwase E, Tawata M, Aida K, Ozaki Y, Kume S, Satoh K, et al. A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with Type 2 diabetes mellitus. Metabolism 1998; 47:699-705.
24. BekT. Glial cell involvement in vascular occlusion of diabetic retinopathy. Acta Ophthalmol Scand 1997; 75:239-43.
25. Michaelson I C. The mode of development of vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc U K 1948; 68:137-80.
26. Meyer-Schwickerath R, Pfeiffer A, Blum W F, Freyberger H, Klein M, Losche C, et al. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J Clin Invest 1993; 92:2620-5.
27. Nishimura M, Ikeda T, Ushiyama M, Nanbu A, Kinoshita S, Yoshimura M. Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. J Clin Endocrinol Metab 1999; 84:659-62.
28. Aiello L P, Avery R L, Arrigg P G, Keyt B A, Jampel H D, Shah S T, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331:1480-7.
29. Adamis A P, Miller J W, Bernal M T, D'Amico D J, Folkman J, Yeo T K, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994; 118:445-50.
30. Miller J W, Adamis A P, Aiello L P. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab Rev 1997; 13:37-50.
31. Aiello L P, Northrup J M, Keyt B A, Takagi H, Iwamoto M A. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995; 113:1538-44.
32. Clermont A C, Aiello L P, Mori F, Aiello L M, Bursell S E. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 1997; 124:433-46.
33. Aiello L P, Bursell S E, Clermont A, Duh E, Ishii H, Takagi C, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 1997; 46: 1473-80.
34. Aiello L P, Pierce E A, Foley E D, Takagi H, Chen H, Riddle L, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptorchimeric proteins. Proc Natl Acad Sci U S A 1995; 92:10457-61.
35. Diabetes Retinopathy Study Research Group. Four risk factors for severe visual loss in diabetic retinopathy. The third report from the DRS. Arch Ophthalmol 1979; 97:654-5.
36. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photograph risk factors for progression of diabetic retinopathy. ETDRS Report No. 12. Ophthalmology 1991; 98:823-33.
37. Early Treatment Diabetic Retinopathy Study Research Group. Fluorescein angiography risk factors for progression of diabetic retinopathy. ETDRS Report No. 13. Ophthalmology 1991; 98:834-40.
38. Diabetes Retinopathy Study Research Group. Diabetes retinopathy study. Report No. 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 1981; 21(Suppl): 210-26.
39. Diabetes Retinopathy Study Research Group. Indications for photocoagulation treatment of diabetic retinopathy: Diabetes Retinopathy Study Report No. 14. Int Ophthalmol Clin 1987; 27:239-53.
40. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. ETDRS Report No. 2. Ophthalmology 1987; 94: 761-74.
41. Early Treatment Diabetic Retinopathy Study Research Group. Effects of aspririn treatment on diabetic retinopathy. ETDRS Report No. 8. Ophthalmology 1991; 98:757-65.
42. Ferris F. Early photocoagulation in patients with either Type I or Type II diabetes. Tran Am Ophthalmol Soc 1996; 94:505-36.
43. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy forsevere vitreous hemorrhage in diabetic retinopathy. 4-year results of a randomized trial: DRVS study report 5. Arch Ophthalmol 1990; 108:958-64.
44. Moloney J B M, Drury M I. The effect of pregnancy on the natural course of diabetic retinopathy. Am J Ophthalmol 1982; 93:745-56.
45. Chew E Y, Klein M L, Ferris F L 3rd, Remaley N A, Murphy R P, Chantry K, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol 1996; 114:1079-84.
46. UKPDS. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317:703-13.
47. Pollack A, Dotan S, Oliver M. Progression of diabetic retinopathy after cataract extraction. Br J Ophthalmol 1991; 75:547-51.
48. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial: DRVS Study Report 3. Ophthalmology 1988; 95:1307-20.
49. Thompson J T, de Bustros S, Michels R G, Rice T A, Glaser B M. Results of vitrectomy for PDR. Ophthalmology 1986; 93:1571-4.
50. Aaberg T M, Abrams G W. Changing indications and techniques for vitrectomy in management of complications of diabetic retinopathy. Ophthalmology 1987; 94:775-9.
51. Quillen D A, GardnerT W, Blakenship G W. Surgical retina. Proliferative diabetic retinopathy. In: Guyer D R, Yannuzzi L A, Chang S, Shields J A, Green D R, editors. Retina-Vitreous-Macula. Philadephia: W B Saunders, 1999.
52. Aiello L M, Cavallerano J D, Aiello L P, Bursell S E. Diabetic retinopathy. In: Guyer D R, Yannuzzi L A, Chang S, Shields J A, Green D R, editors. Retina-Vitreous-Macula. Philadephia: W B Saunders, 1999.